Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ovarian cancer
ovarian cancer
OncoMed Commences Study on OMP-54F28
Yahoo/Zacks
Sat, 02/22/14 - 10:54 am
OncoMed
OMP-54F28
ovarian cancer
Ohr Pharma: A Pure 2014 Catalyst Play With Large Potential
Seeking Alpha
Tue, 11/12/13 - 01:08 pm
Ohr Pharmaceutical
wet-AMD
Squalamine Eye Drops
ovarian cancer
EntreMed commences ENMD-2076 Phase 2 trial
The Fly on the Wall
Thu, 10/31/13 - 11:16 am
ENMD-2076
EntreMed
ovarian cancer
Merrimack - Not Bad News?
Seeking Alpha
Thu, 10/31/13 - 08:52 am
Merrimack Pharmaceuticals
MM-121
ovarian cancer
Odds Favor Endocyte Receiving European Approval For Ovarian Cancer Drug
TheStreet.com
Wed, 10/30/13 - 11:59 am
Endocyte
Europe
ovarian cancer
vintafolide
Roche's Avastin boosts survival in advanced ovarian cancer
Pharma Times, UK
Tue, 10/22/13 - 08:15 am
Roche
ovarian cancer
Avastin
ImmunoGen, Inc. Announces SAR566658 Clinical Findings Reported at AACR-NCI-EORTC Conference
Yahoo/BusinessWire
Sun, 10/20/13 - 02:37 pm
SAR566658
Immunogen
ovarian cancer
breast cancer
skin cancer
Endocyte's Pipeline Encourages
Yahoo/Zacks
Wed, 10/16/13 - 09:24 am
Endocyte
vintafolide
ovarian cancer
non-small cell lung cancer
Endocyte falls after panel says cancer drug isn't working better than older treatment in study
Yahoo/AP
Fri, 10/11/13 - 11:44 am
Endocyte
vintafolide
Docetaxel
ovarian cancer
breast cancer
Myriad Genetics Changes How Doctors Treat Patients
Motley Fool
Mon, 10/7/13 - 07:27 pm
Myriad Genetics
BRCA test
breast cancer
ovarian cancer
Boehringer unit that makes Johnson & Johnson Doxil to shut, WSJ says
Yahoo/Fly on the Wall
Fri, 10/4/13 - 10:10 am
JNJ
Doxil
drug shortages
ovarian cancer
Boehringer Ingelheim
J&J Says Boehringer Doxil Dispute May Cause Shortage
Bloomberg
Wed, 10/2/13 - 10:05 am
JNJ
Boehringer Ingelheim
drug shortages
Doxil
ovarian cancer
3 Cancer Investing Opportunities
Seeking Alpha
Tue, 10/1/13 - 10:10 am
Merck
cancer
AstraZeneca
Bristol-Myers Squibb
MK-1775
ovarian cancer
MK-3475
melanoma
Yervoy
2 Are Better Than 1: Endocyte Uses Diagnostics To Complements Its Drugs
Seeking Alpha
Sun, 09/29/13 - 01:41 pm
Endocyte
diagnostics
EC145
ovarian cancer
Ongoing Phase I Monotherapy Study of Rucaparib in Patients with Solid Tumors Demonstrates Clinical Activity, Establishes Dose and Schedule
Yahoo/BusinessWire
Sun, 09/29/13 - 01:30 pm
Clovis Oncology
ovarian cancer
rucaparib
solid tumors
Endocyte says Doxil supply interruption will not affect PROCEED trial
The Fly on the Wall
Fri, 09/27/13 - 09:11 am
Endocyte
Doxil
JNJ
drug shortages
vintafolide
clinical trials
etarfolatide
ovarian cancer
J&J warns doctors Doxil shortage will hit next month
Fierce Pharma
Thu, 09/26/13 - 02:53 pm
Doxil
ovarian cancer
JNJ
drug shortages
Sun Pharma
AstraZeneca pays $50 million for rights to Merck cancer drug
Yahoo/Reuters
Wed, 09/11/13 - 08:50 am
Merck
AstraZeneca
ovarian cancer
MK-1775
AstraZeneca reverses $285 mln charge as cancer trial starts
Reuters
Wed, 09/4/13 - 09:19 am
AstraZeneca
olaparib
ovarian cancer
BioMarin Announces Oral Presentation of BMN 673 Most Recent Data on Breast and Ovarian Cancers at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sat, 08/17/13 - 10:42 am
Biomarin
BMN 673
breast cancer
ovarian cancer
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
next ›
last »